Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Myovant Sciences Ltd
(NY:
MYOV
)
N/A
UNCHANGED
Last Price
Updated: 7:00 PM EST, Mar 9, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Myovant Sciences Ltd
Myovant Sciences Announces Corporate Updates and Financial Results for Third Fiscal Quarter 2022
January 26, 2023
From
Myovant Sciences, Inc.
Via
GlobeNewswire
MYOVANT SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Myovant Sciences - MYOV
January 25, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
November 16, 2022
From
Myovant Sciences, Inc.
Via
GlobeNewswire
Myovant Sciences Appoints Ann Tomlin as Senior Vice President of Human Resources
November 16, 2022
From
Myovant Sciences, Inc.
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Myovant Sciences Ltd. (NYSE - MYOV), ForgeRock, Inc. (NYSE - FORG), SeaSpine Holdings Corporation (Nasdaq - SPNE), LogicBio Therapeutics, Inc. (Nasdaq – LOGC),
October 31, 2022
From
Brodsky & Smith LLC
Via
GlobeNewswire
Myovant Sciences Announces Corporate Updates and Financial Results for Second Fiscal Quarter 2022
October 26, 2022
From
Myovant Sciences, Inc.
Via
GlobeNewswire
MYOVANT SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Myovant Sciences - MYOV
October 25, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
Myovant Sciences Cancels Second Quarter Earnings Conference Call
October 24, 2022
From
Myovant Sciences, Inc.
Via
GlobeNewswire
MYOV STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Myovant Sciences Ltd. Is Fair to Shareholders
October 24, 2022
From
Halper Sadeh LLC
Via
Business Wire
Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive Agreement
October 23, 2022
From
Myovant Sciences, Inc.
Via
GlobeNewswire
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08
October 18, 2022
From
Myovant Sciences, Inc.
Via
GlobeNewswire
CORRECTION -- Myovant Sciences, Inc.
October 14, 2022
From
Myovant Sciences, Inc.
Via
GlobeNewswire
Myovant Sciences to Host Second Fiscal Quarter 2022 Earnings Conference Call at 5:00 p.m.
October 14, 2022
From
Myovant Sciences, Inc.
Via
GlobeNewswire
Myovant Sciences Special Committee of Board Confirms Receipt of Preliminary, Non-binding Proposal from Sumitovant Biopharma and Sumitomo Pharma to Acquire Remaining Shares
October 02, 2022
From
Myovant Sciences, Inc.
Via
GlobeNewswire
Myovant Sciences Announces Corporate Updates and Financial Results for First Fiscal Quarter 2022
July 27, 2022
From
Myovant Sciences, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.